Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

23 Apr 2009 07:00

RNS Number : 0174R
4imprint Group PLC
23 April 2009
 



4imprint Group plc

Interim Management Statement 

The Board of 4imprint Group plc issues its interim management statement for the period 28 December 2008 to 28 March 2009. Seasonally, the first quarter is the least strong of any quarter of the year, and particularly so for the Direct Marketing Divisionwhich is the largest Division in the Group and in quarter one (Q1) represented 63% of total Group sales.

Group sales for the quarter were £35.72m; 10% ahead of the first quarter last year. At constant currency, sales were 12% lower than in Q1 2008.

Sales performances in each of the three divisions of the Group were as follows:-

(a) End User Division

Q1 sales at £9.92m were 15% lower than Q1 2008. The Manchester based Brand Addition business experienced weak markets carrying into 2009 from the end of last year, and sales were 25% down on Q1 2008. Sales in the Kreyer business were 6% below prior year in sterling and 21% behind in local currencyHowever, the effect on profitability of these two businesses was partly mitigated by cost reduction actions implemented in the first quarter. Sales in PPI have been maintained at a similar level to prior year.

(b) Trade Division

Q1 sales in the Trade Division, including inter divisional salesat £3.90m were 19% down on the same period last year, again reflecting the carry through of the weak trading conditions in the final quarter of 2008.  It is particularly noteworthy that the effect of lower sales during the quarter was completely offset by the major cost reduction implemented during 2008. The Division is now able to focus maximum effort on expanding sales in home and export markets.

(c) Direct Marketing Division

Q1 sales for the Direct Marketing Division at £22.4m were 33% ahead of the same period last year. Constant currency sales in North America in Q1 were 3% below Q1 2008. 

(i) North America 

Over recent years, the Direct Marketing Division has grown rapidly as the Board pursued a strategy of aggressive investment in new customer acquisition through the expansion and development of internet and print marketing techniques. 

Notwithstanding the weaker trading climate in North America from October 2008 onwards, the Board has elected to maintain this prospecting investment, which is a crucial tool in the sustained growth of this important business. In the current trading climate, however, the yields from this investment have reduced and the effect has been amplified by lower average order values than last year, as customers seek to reduce their own costs. Consequently, profitability has been affected and particularly in Q1, which as stated earlier is seasonally the weakest. Most importantly, however, customer retention patterns from customers acquired during the year, as well as those acquired in prior years, have been maintained and total orders have been similar to those of Q1 2008. The business is thus well positioned to continue to gain market share and pursue its opportunity for strong future growth when the economy improves

(ii) UK

Sales continued to grow strongly in this business and were 20% ahead of the same period last year.

Outlook

Trading conditions in our markets continue to look uncertain. However, the Board believes that the range of actions to pursue new sales opportunities coupled with actions already taken to align the cost base and maximise cash flow, should underpin the Group's performance during the coming months.  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRSDGGCD
Date   Source Headline
2nd Apr 20203:34 pmRNSDirector/PDMR Shareholding
1st Apr 202012:03 pmRNSPrice Monitoring Extension
30th Mar 202011:02 amRNSAnnual Financial Report
30th Mar 20208:32 amRNSHolding(s) in Company
26th Mar 202011:43 amRNSHolding(s) in Company
24th Mar 20203:09 pmRNSHolding(s) in Company
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20204:25 pmRNSHolding(s) in Company
5th Mar 20208:49 amRNSHolding(s) in Company
3rd Mar 20202:38 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSFinal Results
26th Feb 20203:55 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSTrading Update and Notice of Final Results
30th Dec 20197:00 amRNSDirectorate Change
23rd Dec 20192:53 pmRNSHolding(s) in Company
18th Dec 20192:46 pmRNSHolding(s) in Company
17th Dec 20193:01 pmRNSEBT Purchase
6th Nov 20198:30 amRNSHolding(s) in Company
5th Nov 20194:24 pmRNSEBT Purchase
4th Nov 20197:00 amRNSTrading Update
29th Oct 20199:01 amRNSEBT Purchase
25th Oct 20199:22 amRNSHolding(s) in Company
17th Oct 20193:51 pmRNSHolding(s) in Company
3rd Oct 20193:55 pmRNSHolding(s) in Company
3rd Oct 20191:14 pmRNSEBT Purchase
2nd Oct 20194:59 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSDirector/PDMR Shareholding
13th Sep 20194:38 pmRNSHolding(s) in Company
9th Sep 20199:11 amRNSEBT Purchase
27th Aug 20192:42 pmRNSDirector/PDMR Shareholding
14th Aug 20199:48 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSHalf-year Report
29th Jul 20198:55 amRNSHolding(s) in Company
12th Jul 20194:28 pmRNSHolding(s) in Company
1st Jul 201910:03 amRNSDirector/PDMR Shareholding
25th Jun 20199:11 amRNSHolding(s) in Company
14th Jun 20199:25 amRNSEBT Purchase
20th May 201911:18 amRNSEBT purchase
7th May 20192:21 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
24th Apr 201911:56 amRNSEBT Purchase
4th Apr 201911:21 amRNSHolding(s) in Company
4th Apr 201911:09 amRNSDirector/PDMR Shareholding
3rd Apr 20198:29 amRNSHolding(s) in Company
1st Apr 20193:57 pmRNSAnnual Financial Report
28th Mar 20193:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.